142 related articles for article (PubMed ID: 17855653)
1. Decursin suppresses human androgen-independent PC3 prostate cancer cell proliferation by promoting the degradation of beta-catenin.
Song GY; Lee JH; Cho M; Park BS; Kim DE; Oh S
Mol Pharmacol; 2007 Dec; 72(6):1599-606. PubMed ID: 17855653
[TBL] [Abstract][Full Text] [Related]
2. Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer.
Jiang C; Lee HJ; Li GX; Guo J; Malewicz B; Zhao Y; Lee EO; Lee HJ; Lee JH; Kim MS; Kim SH; Lu J
Cancer Res; 2006 Jan; 66(1):453-63. PubMed ID: 16397261
[TBL] [Abstract][Full Text] [Related]
3. A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells.
Yim D; Singh RP; Agarwal C; Lee S; Chi H; Agarwal R
Cancer Res; 2005 Feb; 65(3):1035-44. PubMed ID: 15705905
[TBL] [Abstract][Full Text] [Related]
4. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
Jung MH; Lee SH; Ahn EM; Lee YM
Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
[TBL] [Abstract][Full Text] [Related]
5. Involvement of PKC and ROS in the cytotoxic mechanism of anti-leukemic decursin and its derivatives and their structure-activity relationship in human K562 erythroleukemia and U937 myeloleukemia cells.
Kim HH; Sik Bang S; Seok Choi J; Han H; Kim IH
Cancer Lett; 2005 Jun; 223(2):191-201. PubMed ID: 15896453
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of (+)-decursin derivatives as inhibitors of the Wnt/β-catenin pathway.
Lee JH; Kim MA; Park S; Cho SH; Yun E; O YS; Kim J; Goo JI; Yun MY; Choi Y; Oh S; Song GY
Bioorg Med Chem Lett; 2016 Aug; 26(15):3529-32. PubMed ID: 27329797
[TBL] [Abstract][Full Text] [Related]
7. Decursin and decursinol inhibit VEGF-induced angiogenesis by blocking the activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase.
Son SH; Kim MJ; Chung WY; Son JA; Kim YS; Kim YC; Kang SS; Lee SK; Park KK
Cancer Lett; 2009 Jul; 280(1):86-92. PubMed ID: 19307054
[TBL] [Abstract][Full Text] [Related]
8. Decursin from Angelicagigas Nakai induces apoptosis in RC-58T/h/SA#4 primary human prostate cancer cells via a mitochondria-related caspase pathway.
Choi SR; Lee JH; Kim JY; Park KW; Jeong IY; Shim KH; Lee MK; Seo KI
Food Chem Toxicol; 2011 Oct; 49(10):2517-23. PubMed ID: 21693165
[TBL] [Abstract][Full Text] [Related]
9. Decursin: a cytotoxic agent and protein kinase C activator from the root of Angelica gigas.
Ahn KS; Sim WS; Kim IH
Planta Med; 1996 Feb; 62(1):7-9. PubMed ID: 8720379
[TBL] [Abstract][Full Text] [Related]
10. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
11. Polysiphonia japonica extract suppresses the Wnt/beta-catenin pathway in colon cancer cells by activation of NF-kappaB.
Gwak J; Park S; Cho M; Song T; Cha SH; Kim DE; Jeon YJ; Shin JG; Oh S
Int J Mol Med; 2006 Jun; 17(6):1005-10. PubMed ID: 16685408
[TBL] [Abstract][Full Text] [Related]
12. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
Yang Q; Titus MA; Fung KM; Lin HK
J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
[TBL] [Abstract][Full Text] [Related]
13. Decursin and decursinol angelate selectively inhibit NADH-fumarate reductase of Ascaris suum.
Shiomi K; Hatano H; Morimoto H; Ui H; Sakamoto K; Kita K; Tomoda H; Lee EW; Heo TR; Kawagishi H; Omura S
Planta Med; 2007 Nov; 73(14):1478-81. PubMed ID: 17948169
[TBL] [Abstract][Full Text] [Related]
14. WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics.
Bisson I; Prowse DM
Cell Res; 2009 Jun; 19(6):683-97. PubMed ID: 19365403
[TBL] [Abstract][Full Text] [Related]
15. Decursinol and decursin protect primary cultured rat cortical cells from glutamate-induced neurotoxicity.
Kang SY; Kim YC
J Pharm Pharmacol; 2007 Jun; 59(6):863-70. PubMed ID: 17637179
[TBL] [Abstract][Full Text] [Related]
16. Decursinol angelate: a cytotoxic and protein kinase C activating agent from the root of Angelica gigas.
Ahn KS; Sim WS; Lee IK; Seu YB; Kim IH
Planta Med; 1997 Aug; 63(4):360-1. PubMed ID: 9270380
[TBL] [Abstract][Full Text] [Related]
17. Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling.
Prasad CP; Rath G; Mathur S; Bhatnagar D; Ralhan R
Chem Biol Interact; 2009 Oct; 181(2):263-71. PubMed ID: 19573523
[TBL] [Abstract][Full Text] [Related]
18. Biotransformation of plant secondary metabolite decursin by Mycobacterium sp. PYR1001.
Kim KY; Lee S; Cha CJ
J Agric Food Chem; 2010 Mar; 58(5):2931-4. PubMed ID: 20155945
[TBL] [Abstract][Full Text] [Related]
19. In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin.
Lee HJ; Lee HJ; Lee EO; Lee JH; Lee KS; Kim KH; Kim SH; Lü J
Am J Chin Med; 2009; 37(1):127-42. PubMed ID: 19222117
[TBL] [Abstract][Full Text] [Related]
20. Calreticulin mediated glucocorticoid receptor export is involved in beta-catenin translocation and Wnt signalling inhibition in human osteoblastic cells.
Olkku A; Mahonen A
Bone; 2009 Apr; 44(4):555-65. PubMed ID: 19100874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]